NCT00004806

Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis

Study Summary

OBJECTIVES: Evaluate the efficacy and safety of lipid-mediated transfer of the cystic fibrosis transmembrane conductance regulator gene to nasal epithelium in patients with cystic fibrosis.

Interested in this trial?

Submit an Inquiry

Interventions

Cystic fibrosis transmembrane conductance regulatorGENETIC
No description available.

Study Locations

No locations listed.

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: May 29, 2026